Ignite Creation Date:
2024-05-06 @ 12:17 AM
Last Modification Date:
2024-10-26 @ 10:47 AM
Study NCT ID:
NCT01534546
Status:
UNKNOWN
Last Update Posted:
2019-09-17
First Post:
2012-02-13
Brief Title:
Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1SOX Versus SOX or Oxaliplatin With Capecitabine XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection
Sponsor:
Organization:
Peking University
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
1094
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: